General Counsel and Corporate Secretary · Niagen Bioscience, Inc. (NAGE)

Mark Friedman

A named executive officer of Niagen Bioscience in every fiscal year CompBrief holds from FY2018 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$678,767

Salary $311,971Stock awards $0

FY2019: $622,097

5th of 5 named executive officers at Niagen Bioscience by FY2020 total.

5 named officers on file for Niagen Bioscience, FY2020

Mark Friedman’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Niagen Bioscience’s whole pay program stands against its peers

  • Niagen Bioscience’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NAGE→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 21, 2021 (DEF 14A).

Free

Get Mark Friedman’s full pay file as a PDF — free

More than this page: up to 10 years of Mark’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Mark Friedman compensation by year

Niagen Bioscience Summary Compensation Table · all 3 fiscal years held
In US dollars, as Niagen Bioscience reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019FY2020
Salary$281,967$306,577$311,971
Bonus$87,974$98,058$0
Stock awards$0$0$0
Option awards$1,768,274$210,450$209,217
Non-equity incentive$0$0$149,507
Pension and deferred compensation$0$0$0
All other$6,231$7,012$8,072
Total$2,144,446$622,097$678,767

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Niagen Bioscience, Inc. DEF 14A filed April 21, 2021, accession 0001654954-21-004465, and prior-year filings.

How this page was built: the Niagen Bioscience, Inc. filed document, accession 0001654954-21-004465. Every figure is read from that document and cited to the page and table it appears in. Filed April 21, 2021.

$2.1M
$622K
$679K
FY18
FY19
FY20
SalaryBonusNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
Option13,889—$5.65
Option34,710—$3.84
Option109,054—$3.27

Per the Outstanding Equity Awards at Fiscal Year-End table in Niagen Bioscience, Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

Niagen Bioscience’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Robert FriedChief Executive Officer$1,126,685
Megan JordanFormer Chief Marketing Officer$774,196
Frank Jaksch Jr.Former Executive Chairman, Current Chairman of the Board$734,678
Kevin FarrFormer Chief Financial Officer$688,816
Mark Friedman · this pageGeneral Counsel and Corporate Secretary$678,767

The full Niagen Bioscience compensation record

free company brief

This page is one person within Niagen Bioscience's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Niagen Bioscience's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Mark Friedman's compensation dossier · One-time report. No refunds.